Amid Philips’ recent recall of more than 2 million CPAP and sleep apnea devices, competitor ResMed is looking to gain market share, reports Fierce Biotech. But challenges exist—namely global shortages of essential computer chips.
Read More
Baxter has initiated a safety recall for its Spectrum Dose IQ Safety Software due to a potentially life-threatening defect in which incorrect drug-dosing information could be transmitted to the company’s Spectrum IQ Infusion System. The potential for patient harm is so serious, in fact, that the U.S. FDA has categorized it as a Class 1 recall.
Read More
Mike Busdicker grew up on a northwestern Ohio horse farm—a childhood that fed his fascination with the rodeo. Early on, he decided to pursue a career as a professional bull rider. Fortunately for the HTM field, he pivoted his direction.
Read More
On Tuesday, August 3, the U.S. FDA categorized the recent recall of some of Philips’ ventilators as Class 1—the most critical type—stating that their usage could cause injuries or, worse, death. This marks the second Class 1 recall initiated by Philips in 2021.
Read More
An analysis of the U.S. FDA’s Manufacturer and User Facility Device Experience database has discovered that medical device-associated patient deaths are being mislabeled in the system—mistakes that could impede patient care.
Read More